[NBIX] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
01-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 81.45%
YoY- 69.84%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 96,905 71,086 94,517 60,774 6,335 0 0 -
PBT -5,913 -41,818 6,894 -11,125 -59,985 -78,326 -44,659 -74.11%
Tax 7,591 7,504 6,686 7,337 4,767 -1,606 -2,024 -
NP -5,913 -41,818 6,894 -11,125 -59,985 -78,326 -44,659 -74.11%
Tax Rate - - -96.98% - - - - -
Total Cost 102,818 112,904 87,623 71,899 66,320 78,326 44,659 74.62%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin -6.10 -58.83 7.29 -18.31 -946.88 0.00 0.00 -
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -0.07 -0.47 0.08 -0.13 -0.68 -0.90 -0.51 -73.48%
EPS Diluted -0.07 -0.47 0.07 -0.13 -0.68 -0.90 -0.51 -73.48%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.